Brian Lavey

Person

New Providence, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of IRAK4 activity
- Patent number 9,598,440
- Issue date Mar 21, 2017
- Merck Sharp & Dohme Corp.
- W. Michael Seganish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused tetracycle derivatives and methods of use thereof for the tre...
- Patent number 9,254,292
- Issue date Feb 9, 2016
- Merck Sharp & Dohme Corp.
- Craig A. Coburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aminopyrimidinones as interleukin receptor-associated kinase inhibi...
- Patent number 9,221,809
- Issue date Dec 29, 2015
- Merck Sharp & Dohme Corp.
- W. Michael Seganish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 8,859,529
- Issue date Oct 14, 2014
- Merck Sharp & Dohme Corp.
- Bandarpalle B. Shankar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 8,569,336
- Issue date Oct 29, 2013
- Ling Tong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 8,541,572
- Issue date Sep 24, 2013
- Merck Sharp & Dohme Corp.
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory diseases
- Patent number 8,450,355
- Issue date May 28, 2013
- Merck Sharp & Dohme Corp.
- Michael K. C. Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-imidazolone derivatives as glucagon receptor antagonists
- Patent number 8,361,959
- Issue date Jan 29, 2013
- Merck Sharp & Dohme Corp.
- Andrew Stamford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 8,178,553
- Issue date May 15, 2012
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,879,890
- Issue date Feb 1, 2011
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,772,263
- Issue date Aug 10, 2010
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor ligands
- Patent number 7,718,702
- Issue date May 18, 2010
- Schering Corporation
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,687,527
- Issue date Mar 30, 2010
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,683,085
- Issue date Mar 23, 2010
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,683,088
- Issue date Mar 23, 2010
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,652,020
- Issue date Jan 26, 2010
- Schering Corporation
- Zhuyan Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor ligands
- Patent number 7,645,774
- Issue date Jan 12, 2010
- Schering Corporation
- Richard J. Friary
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,598,242
- Issue date Oct 6, 2009
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,524,842
- Issue date Apr 28, 2009
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor ligands
- Patent number 7,507,767
- Issue date Mar 24, 2009
- Schering Corporation
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,504,424
- Issue date Mar 17, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,488,745
- Issue date Feb 10, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,482,370
- Issue date Jan 27, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor ligands
- Patent number 7,071,213
- Issue date Jul 4, 2006
- Schering Corporation
- Richard J. Friary
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor ligands
- Patent number 7,067,539
- Issue date Jun 27, 2006
- Schering Corporation
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 7,034,057
- Issue date Apr 25, 2006
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of inflammatory disorders
- Patent number 6,838,466
- Issue date Jan 4, 2005
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted oximes as neurokinin antagonists
- Patent number 6,063,926
- Issue date May 16, 2000
- Schering Corporation
- Gregory A. Reichard
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20150299224
- Publication date Oct 22, 2015
- MERCK SHARP & DOHME CORP.
- W. MICHAEL SEGANISH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINOPYRIMIDINONES AS INTERLEUKIN RECEPTOR-ASSOCIATED KINASE INHIBI...
- Publication number 20140329799
- Publication date Nov 6, 2014
- W. Michael Seganish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TRE...
- Publication number 20140170111
- Publication date Jun 19, 2014
- Merck Sharp & Dohmn Corp.
- Craig A. Coburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSIT...
- Publication number 20130012434
- Publication date Jan 10, 2013
- Michael K. Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIRO IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONIST...
- Publication number 20130012493
- Publication date Jan 10, 2013
- He Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20120015926
- Publication date Jan 19, 2012
- Ling Tong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20120010181
- Publication date Jan 12, 2012
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES
- Publication number 20110288077
- Publication date Nov 24, 2011
- Schering Corporation
- Michael K.C. Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20110288054
- Publication date Nov 24, 2011
- Schering Corporation
- Bandarpalle B. Shankar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS
- Publication number 20110178007
- Publication date Jul 21, 2011
- Schering Corporation
- Andrew Stamford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20100145048
- Publication date Jun 10, 2010
- Schering Corporation
- Zhuyan Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20100120838
- Publication date May 13, 2010
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090170875
- Publication date Jul 2, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090156586
- Publication date Jun 18, 2009
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090137586
- Publication date May 28, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20090111803
- Publication date Apr 30, 2009
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20070265299
- Publication date Nov 15, 2007
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20070219218
- Publication date Sep 20, 2007
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20070197564
- Publication date Aug 23, 2007
- Schering Corporation
- Brian J. Lavey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060276506
- Publication date Dec 7, 2006
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060252778
- Publication date Nov 9, 2006
- Zhuyan Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060205797
- Publication date Sep 14, 2006
- Schering Corporation
- Wensheng Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20060063843
- Publication date Mar 23, 2006
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cannabinoid receptor ligands
- Publication number 20060009528
- Publication date Jan 12, 2006
- Schering Corporation
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cannabinoid receptor ligands
- Publication number 20050282861
- Publication date Dec 22, 2005
- Richard J. Friary
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20040102418
- Publication date May 27, 2004
- Zhoaning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of inflammatory disorders
- Publication number 20040038941
- Publication date Feb 26, 2004
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cannabinoid receptor ligands
- Publication number 20040010013
- Publication date Jan 15, 2004
- Schering Corporation
- Richard J. Friary
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cannabinoid receptor ligands
- Publication number 20030232859
- Publication date Dec 18, 2003
- Schering Corporation
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cannabinoid receptor ligands
- Publication number 20030096844
- Publication date May 22, 2003
- Schering Corporation
- Joseph A. Kozlowski
- C07 - ORGANIC CHEMISTRY

Brian Lavey

Person

Patents Grantslast 30 patents

Inhibitors of IRAK4 activity

Fused tetracycle derivatives and methods of use thereof for the tre...

Aminopyrimidinones as interleukin receptor-associated kinase inhibi...

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory diseases

Spiro-imidazolone derivatives as glucagon receptor antagonists

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Substituted oximes as neurokinin antagonists

Patents Applicationslast 30 patents

INHIBITORS OF IRAK4 ACTIVITY

AMINOPYRIMIDINONES AS INTERLEUKIN RECEPTOR-ASSOCIATED KINASE INHIBI...

FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TRE...

NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSIT...

NOVEL SPIRO IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONIST...

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

SPIRO-IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Cannabinoid receptor ligands

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Cannabinoid receptor ligands

Cannabinoid receptor ligands

Cannabinoid receptor ligands